Discovery and characterization of selective orexin receptor antagonists

被引：0

作者：

Shireman, Brock T. ^{[1
]}

Bonaventure, Pascal ^{[1
]}

Letavic, Michael A. ^{[1
]}

Lebold, Terry A. ^{[1
]}

Dugovic, Christine ^{[1
]}

Lord, Brian ^{[1
]}

Morton, Kirsten L. ^{[1
]}

Nepomuceno, Diane ^{[1
]}

Shelton, Jonathan ^{[1
]}

Aluisio, Leah ^{[1
]}

Fraser, Ian ^{[1
]}

Acton, Paul ^{[2
]}

Johnson, Phil ^{[3
]}

Shekhar, Anantha ^{[4
]}

Lovenberg, Timothy W. ^{[1
]}

Carruthers, Nicholas I. ^{[1
]}

机构：

[1] Janssen Pharmaceut Res & Dev LLC, San Diego, CA 92121 USA

[2] Janssen Pharmaceut Res & Dev LLC, Spring House, PA 19477 USA

[3] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA

[4] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2014年 / 248卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

333-MEDI

引用

页数：1

共 50 条

[31] Effect of 1-Substitution on Tetrahydroisoquinolines as Selective Antagonists for the Orexin-1 Receptor
Perrey, David A.
German, Nadezhda A.
Decker, Ann M.
Thorn, David
Li, Jun-Xu
Gilmour, Brian P.
Thomas, Brian F.
Harris, Danni L.
Runyon, Scott P.
Zhang, Yanan
ACS CHEMICAL NEUROSCIENCE, 2015, 6 (04): : 599 - 614
[32] Discovery of orexin 2 receptor selective and dual orexin receptor agonists based on the tetralin structure: Switching of receptor selectivity by chirality on the tetralin ring
Iio, Keita
Saitoh, Tsuyoshi
Ohshita, Ryuichiro
Hino, Tsubasa
Amezawa, Mao
Takayama, Yoshiaki
Nagumo, Yasuyuki
Yamamoto, Naoshi
Kutsumura, Noriki
Irukayama-Tomobe, Yoko
Ishikawa, Yukiko
Tanimura, Ryuji
Yanagisawa, Masashi
Nagase, Hiroshi
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 60
[33] Discovery of Highly Potent Dual Orexin Receptor Antagonists via a Scaffold-Hopping Approach
Heidmann, Bibia
Gatfield, John
Roch, Catherine
Treiber, Alexander
Tortoioli, Simone
Brotschi, Christine
Williams, Jodi T.
Bolli, Martin H.
Abele, Stefan
Sifferlen, Thierry
Jenck, Francois
Boss, Christoph
CHEMMEDCHEM, 2016, 11 (19) : 2132 - 2146
[34] Discovery and optimisation of 1-acyl-2-benzylpyrrolidines as potent dual orexin receptor antagonists
Williams, Jodi T.
Gatfield, John
Roch, Catherine
Treiber, Alexander
Jenck, Francois
Bolli, Martin H.
Brotschi, Christine
Sifferlen, Thierry
Heidmann, Bibia
Boss, Christoph
MEDCHEMCOMM, 2015, 6 (06) : 1054 - 1064
[35] Discovery and Characterization of Carbamothioylacrylamides As EP2 Selective Antagonists
Ganesh, Thota
Jiang, Jianxiong
Shashidharamurthy, Rangaiah
Dingledine, Ray
ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (07): : 51 - 56
[36] Discovery of an orexin receptor positive potentiator
Lee, Jiyong
Reddy, M. Muralidhar
Kodadek, Thomas
CHEMICAL SCIENCE, 2010, 1 (01) : 48 - 54
[37] Orexin receptor antagonists: a new treatment for insomnia?
Riemann, Dieter
Spiegelhalder, Kai
LANCET NEUROLOGY, 2014, 13 (05): : 441 - 443
[38] Opportunities and perspectives for developing orexin receptor antagonists
Barnes, Nicholas M.
FRONTIERS IN NEUROSCIENCE, 2014, 8
[39] Substituted Azabicyclo[2.2.1]heptanes as Selective Orexin-1 Antagonists: Discovery of JNJ-54717793
Preville, Cathy
Bonaventure, Pascal
Koudriakova, Tatiana
Lord, Brian
Nepomuceno, Diane
Rizzolio, Michele
Mani, Neelakandha
Coe, Kevin J.
Ndifor, Anthony
Dugovic, Christine
Dvorak, Curt A.
Coate, Heather
Pippel, Daniel J.
Fitzgerald, Anne
Allison, Brett
Lovenberg, Timothy W.
Carruthers, Nicholas, I
Shireman, Brock T.
ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (10): : 2002 - 2009
[40] Orexin receptor antagonists as therapeutic agents for insomnia
Equihua, Ana C.
De La Herran-Arita, Alberto K.
Drucker-Colin, Rene
FRONTIERS IN PHARMACOLOGY, 2013, 4

← 1 2 3 4 5 →